Skip to main content
. 2019 Feb 5;9(2):54. doi: 10.3390/biom9020054

Table 8.

Viability of NTS (%) following exposure to anticancer drugs, antioxidants, drug combinations, and combination indexes.

Viability (%)
Anticancer AntiOx Combination Combination Index
VDT + Flav 29.4 67.6 0.02 1.03
VDT + Resv 29.4 64.7 0.09 1.06
IMT + Flav 77.3 89.4 77.1 1.45
IMT + Resv 72.3 64.7 64.1 1.75
IMT + Mel 77.3 98.1 91.3 2.83